PFE. Pfizer’s XALKORI® Receives Conditional Marketing Authorization from the European Commission for the Treatment of Adults with Previously Treated ALK-Positive Advanced Non-Small Cell Lung Cancer in the EU http://finance.yahoo.com/news/pfizer-xalkori-receives-conditional-marketing-150000551.html stockcharts.com/c-sc/sc?s=PFE&p=W&yr=1&mn=0&dy=0&i=t86945340163&r=1351110160992